| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |